Diagnostic Performance of Non-Invasive Tests in Assessing Liver Fibrosis Among Type 2 Diabetes Mellitus.

[Noninvasive scores for predicting liver-related events in patients with metabolic dysfunction-associated fatty liver disease].

Non-Invasive Assessment of Liver Steatosis and Fibrosis Using Transient Elastography in a Tertiary Care Hospital: A Cross-Sectional Study among Patients with Type 2 Diabetes Mellitus

Background: Metabolic dysfunction–associated steatotic liver disease (MASLD) is highly prevalent in people with type 2 diabetes mellitus (T2DM), and fibrosis stage is the strongest determinant of liver-related outcomes. Liver biopsy is diagnostic but invasive and unsuitable for routine risk stratification. Vibration-co...

Predictors of Hepatic Steatosis and the Limitations of the FIB-4 Index in Type 2 Diabetes: A Cross-Sectional Study

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is highly prevalent among patients with type 2 diabetes mellitus (T2DM). Non-invasive tools (NITs) such as the FIB-4 index, are widely used for risk stratification to identify patients at higher risk of progressive liver disease. This study aim...

Screening for metabolic dysfunction-associated steatotic liver disease in type 2 diabetes patients using the fibrosis-4 score in medina-retrospective study

Type 2 diabetes mellitus (T2DM) is a global health problem closely linked to metabolic dysfunction-associated steatotic liver disease (MASLD) and advanced fibrosis. The fibrosis-4 (FIB-4) index is a standard noninvasive tool for estimating fibrosis risk. This study aimed to describe the demographics, metabolic para...

Evaluation of Non-Alcoholic Fatty Liver Disease Severity Using FIB-4 Score and Transient Elastography in Type-2 Diabetes Patients

Background: Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease. Fibrosis-4 (FIB-4) score is a screening tool for liver fibrosis detection and Transient elastography (TE) is recommended for liver stiffness measurement (LSM) in primary care settings for patients with metabolic risk facto...

Prevalence of advanced hepatic fibrosis and non-invasive scores for type 2 diabetics with MASLD: Prospective study in a resource-limited Indian setting

Metabolic dysfunction-associated steatotic liver disease is an important cause of chronic liver disease in patients with Type 2 diabetes mellitus, with advanced hepatic fibrosis substantially increasing liver-related morbidity and mortality. Therefore, it is of interest to evaluate the 120 patients with Type 2 diabetes...